Chiral Technologies, Inc.
Chiral Technologies, Inc. provides products and custom services for resolution of racemic compounds by enantioselective chromatography.
Company Description
Chiral Technologies, Inc. provides products and custom services for resolution of racemic compounds by enantioselective chromatography. The products comprise high-performance liquid chromatography (HPLC) and supercritical fluid chromatography (SFC) columns for analytical, semi-preparative, and preparative enantioselective resolutions, as well as bulk chiral stationary phases, including the innovative immobilized phases CHIRALPAK® IA™, IB™, and IC™. Services range from method development through custom separation solutions for the purification of milligram to multi-kilogram quantities. In addition, process development and pilot studies are offered for projects outsourced for late-stage clinical development. The company is a wholly-owned subsidiary of the Japanese fine chemical producer, Daicel Chemical Industries, Ltd.
Markets Served
Chiral Technologies, the worldwide market leader in enantioselective chromatography, serves the pharmaceutical, agrochemical, and life science industries. Our HPLC and SFC columns are used by pharmaceutical researchers to aid both drug discovery and process development efforts. Custom separation services provide the fastest route from early-stage clinical drug development to market. Our CSPs, including the innovative immobilized phases, play a vital role in the commercial development and manufacture of single-enantiomer products.
Major Products/Services
Industry-standard Daicel columns:
- Revolutionary immobilized CSPs, including IA, IB, and IC, are offered for the resolution of low-solubility compounds and afford a new level of robustness.
- Newly introduced columns, packed with 3-µm particles, are designed for high-throughput screening.
- Bulk chiral stationary phases are supplied for process-scale enantioselective chromatography.
Protein-based chiral columns:
- Chiral-AGP has extremely broad applicability for the separation of chiral drugs.
- Chiral-CBH is effective for the separation of basic drugs of many compound types.
- Chiral-HSA can be used to separate acidic compounds and nonprotolytic compounds.
Custom separations:
- Custom separation services employ HPLC and SFC with purification capability from milligram up to 20 kg of racemate.
- A lab-scale simulated moving bed (SMB) is available for purification of up to 50 to 70 kg of racemate and for establishing operating conditions and economics related to commercial-scale development.
Facilities
Chiral Technologies' headquarters, including a state-of-the-art technical center, is located in West Chester, Pennsylvania. Fully staffed and equipped technical centers are also located in Strasbourg, France (Chiral Technologies Europe) and at Daicel manufacturing plants in Japan.
Chiral Technologies, Inc.
800 North Five Points Road, West Chester, PA 19380
TELEPHONE
800-6CHIRAL (800-624-4725)
(610) 594-2100
FAX
(610) 594-2325
WEB SITE
NUMBER OF EMPLOYEES
30
YEAR FOUNDED
1990
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
6PPD-Quinone Reference Materials
November 19th 2024Ensure environmental and consumer health with our standards for 6PPD-quinone testing. 6PPD-quinone has been detected in the environment and has shown toxicity to aquatic life. Chiron, by Zeptometrix® offers reference standards suitable for Draft EPA Method 1634.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Microplastics Reference Materials
November 19th 2024The World’s First Microplastics Reference Materials. Our scientists have focused on these emerging global threats, and are excited to share Chiron MicroPrefs®, the first commercial microplastic reference material. The MicroPref® portfolio is designed to detect the six most abundant plastics in the environment and is available in a novel, easy-to-use tablet formulation. Be among the first labs to join in the fight against microplastic pollution by exploring the NEW line of Chiron MicroPrefs® microplastic standards.
RAFA 2024 Highlights: Cutting-Edge Chromatography Techniques for Food Safety and Food Analysis
November 18th 2024An illuminating session focusing on progress in analytical techniques used in food analysis took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, The Czech Republic, including a talk on the analysis of 1000 toxins in 10 minutes.
